Puma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company (“Puma” or the “Company”), today announced financial results for the fourth quarter and year ended December 31, 2012.
Unless otherwise stated, all comparisons are for the fourth quarter and full year 2012, compared to the fourth quarter and full year 2011, respectively.
